Molecular diagnostic company Trovagene has appointed Charlie Rodi to vice president and chief technology officer. Previous positions include director of the Monsanto Genome Sequencing Center and executive vice president of genomics at Sequenom. He has also held positions at G.D. Searle, where he helped use nucleic acid biomarkers in drug development, and at ICx BioSystems, where he helped establish the use of digital PCR in the detection of rare alleles in circulating nucleic acids. He holds a PhD in cellular and developmental biology from the University of Minnesota-Twin Cities and a BA in biology from the University of Missouri-Columbia.
Steven Hyman has been appointed to lead the Broad Institute's Stanley Center for Psychiatric Research, which will use genomics to understand the neurobiology of and develop therapeutics for neuropsychiatric diseases. He will take over from Edward Scolnick, the founding director, who will remain as a faculty member at the Broad and become chief scientist at the Stanley Center.
Hyman was provost at Harvard University for 10 years, until he stepped down in June and joined the Broad as a scholar-in-residence at the Stanley Center. He was also formerly the director of the National Institute of Mental Health. He holds degrees from Yale College, the University of Cambridge, and Harvard Medical School.